The objective of this study is to investigate whether topical application of tranexamic acid into the uterine cavity and the surgical site intra-operatively can reduce blood loss and provide better surgical haemostasis in parturients with moderate to high risk for bleeding undergoing caesarean deliveries.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Total intra-operative blood loss in the Tranexamic Acid (TXA) group compared to the Control group
Timeframe: From the start of the surgery (first surgical incision) up to the end of the surgery (at wound closure)